Improving fat function through blood vessel development
Energizing good fat by neurovascular development
This study is looking at how a special protein can help create more blood vessels in fat tissue, which might help people with obesity and insulin resistance, and it aims to understand how this protein works with another one to boost energy use in fat cells, potentially leading to new ways to treat metabolic issues.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11012335 on NIH RePORTER |
What this research studies
This research investigates how a specific growth factor, vascular endothelial growth factor-A, can enhance blood vessel formation in fat tissue, which may help combat obesity and insulin resistance. The study will explore the interaction between this growth factor and another factor called angiopoietin-2 to understand how they work together to improve energy expenditure in fat cells. By using advanced genetic models, the research aims to uncover the mechanisms that promote healthy fat function and potentially lead to new treatments for metabolic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with obesity or insulin resistance, particularly those with adult-onset diabetes.
Not a fit: Patients who are not overweight or do not have metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating obesity and related metabolic conditions by enhancing the function of fat tissue.
How similar studies have performed: Previous research has shown promising results in enhancing fat function through blood vessel development, indicating that this approach may be effective.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Daquinag, Alexes — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Daquinag, Alexes
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.